These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28515797)

  • 1. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.
    Rahier JF; Druez A; Faugeras L; Martinet JP; Géhénot M; Josseaux E; Herzog M; Micallef J; George F; Delos M; De Ronde T; Badaoui A; D'Hondt L
    Clin Epigenetics; 2017; 9():53. PubMed ID: 28515797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
    Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
    Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR.
    Ciarloni L; Hosseinian S; Monnier-Benoit S; Imaizumi N; Dorta G; Ruegg C;
    PLoS One; 2015; 10(4):e0123904. PubMed ID: 25876024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation?
    Worm Ørntoft MB
    Clin Colorectal Cancer; 2018 Jun; 17(2):e415-e433. PubMed ID: 29678513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps.
    Cassinotti E; Melson J; Liggett T; Melnikov A; Yi Q; Replogle C; Mobarhan S; Boni L; Segato S; Levenson V
    Int J Cancer; 2012 Sep; 131(5):1153-7. PubMed ID: 22020530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of colorectal cancer: from conventional methods to novel biomarkers.
    Vatandoost N; Ghanbari J; Mojaver M; Avan A; Ghayour-Mobarhan M; Nedaeinia R; Salehi R
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):341-51. PubMed ID: 25687380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.
    Rodia MT; Solmi R; Pasini F; Nardi E; Mattei G; Ugolini G; Ricciardiello L; Strippoli P; Miglio R; Lauriola M
    Clin Colorectal Cancer; 2018 Jun; 17(2):e217-e228. PubMed ID: 29352642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer.
    Gezer U; Yörüker EE; Keskin M; Kulle CB; Dharuman Y; Holdenrieder S
    Int J Mol Sci; 2015 Dec; 16(12):29654-62. PubMed ID: 26690425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
    Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
    Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer.
    Melson J; Li Y; Cassinotti E; Melnikov A; Boni L; Ai J; Greenspan M; Mobarhan S; Levenson V; Deng Y
    Int J Cancer; 2014 Jun; 134(11):2656-62. PubMed ID: 24288256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
    Heiss JA; Brenner H
    Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A blood-based biomarker panel for stratifying current risk for colorectal cancer.
    Marshall KW; Mohr S; Khettabi FE; Nossova N; Chao S; Bao W; Ma J; Li XJ; Liew CC
    Int J Cancer; 2010 Mar; 126(5):1177-86. PubMed ID: 19795455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
    Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
    BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma methylated septin 9: a colorectal cancer screening marker.
    Molnár B; Tóth K; Barták BK; Tulassay Z
    Expert Rev Mol Diagn; 2015 Feb; 15(2):171-84. PubMed ID: 25429690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study.
    Wei SC; Tsao PN; Wang YT; Lin BR; Wu DC; Tsai WS; Chen JS; Wong JM
    Cancer Med; 2019 Jul; 8(7):3583-3591. PubMed ID: 31063258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study.
    Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W
    Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
    Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
    Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
    Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O
    PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.